Primary use of the venovenous approach for extracorporeal membrane oxygenation in pediatric acute respiratory failure*

Objectives To describe a single center’s experience with the primary use of venovenous cannulation for supporting pediatric acute respiratory failure patients with extracorporeal membrane oxygenation (ECMO). Design Retrospective chart review of all patients receiving extracorporeal life support at a single institution. Setting Pediatric intensive care unit at a tertiary care children’s hospital. Patients Eighty-two patients between the ages of 2 wks and 18 yrs with severe acute respiratory failure. Interventions ECMO for acute respiratory failure. Measurements and Main Results From January 1991 until April 2002, 82 pediatric patients with acute respiratory failure were cannulated for ECMO support. Median duration of ventilation before ECMO was 5 days (range, 1–17 days). Sixty-eight of these patients (82%) initially were placed on venovenous ECMO. Fourteen patients were initiated and remained on venoarterial support, including six in whom venovenous cannulae could not be placed. One patient was converted from venovenous to venoarterial support due to inadequate oxygenation. Venoarterial patients had significantly greater alveolar-arterial oxygen gradients and lower Pao2/Fio2 ratios than venovenous patients (p < .03). Fifty-five of 81 venovenous patients received additional drainage cannulae (46 of 55 with an internal jugular cephalad catheter). Thirty-five percent of venovenous patients and 36% of venoarterial patients required at least one vasopressor infusion at time of cannulation (p = nonsignificant); vasopressor dependence decreased over the course of ECMO in both groups. Median duration on venovenous ECMO for acute hypoxemic respiratory failure was 218 hrs (range, 24–921). Venovenous ECMO survivors remained cannulated for significantly shorter time than nonsurvivors did (median, 212 vs. 350 hrs; p = .04). Sixty-three of 82 ECMO (77%) patients survived to discharge—56 of 68 venovenous ECMO (81%) and nine of 14 venoarterial ECMO (64%). Conclusions Venovenous ECMO can effectively provide adequate oxygenation for pediatric patients with severe acute respiratory failure receiving ECMO support. Additional cannulae placed at the initiation of venovenous ECMO could be beneficial in achieving flow rates necessary for adequate oxygenation and lung rest.

[1]  A. Pigna,et al.  Multicenter, randomized, controlled study of porcine surfactant in severe respiratory syncytial virus-induced respiratory failure* , 2002, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[2]  P. Rycus,et al.  The changing demographics of neonatal extracorporeal membrane oxygenation patients reported to the Extracorporeal Life Support Organization (ELSO) Registry. , 2000, Pediatrics.

[3]  J. Younger,et al.  Extracorporeal life support: the University of Michigan experience. , 2000, JAMA.

[4]  R. Bartlett,et al.  Venovenous versus venoarterial extracorporeal life support for pediatric respiratory failure: Are there differences in survival and acute complications? , 2000, Critical care medicine.

[5]  R. Bartlett,et al.  Extracorporeal life support outcome for 128 pediatric patients with respiratory failure. , 2000, Journal of pediatric surgery.

[6]  J. Fackler,et al.  Extracorporeal membrane oxygenation and pediatric acute respiratory distress syndrome: we can afford it, but we don't need it. , 1998, Critical care medicine.

[7]  R. Pettignano,et al.  Total enteral nutrition versus total parenteral nutrition during pediatric extracorporeal membrane oxygenation , 1998, Critical care medicine.

[8]  R. Clark,et al.  The use of cephalad cannulae to monitor jugular venous oxygen content during extracorporeal membrane oxygenation , 1998, Critical care.

[9]  L. Graziani,et al.  Cerebrovascular complications and neurodevelopmental sequelae of neonatal ECMO. , 1997, Clinics in perinatology.

[10]  B. Warner,et al.  Extracorporeal Life Support for the Treatment of Viral Pneumonia: Collective Experience From the ELSO Registry , 1997 .

[11]  R. Clark,et al.  Principles and Practice of Venovenous Extracorporeal Membrane Oxygenation , 1996 .

[12]  G. Dudell,et al.  A comparison of venovenous and venoarterial extracorporeal membrane oxygenation in the treatment of neonatal respiratory failure. , 1996, Critical care medicine.

[13]  T. Weber,et al.  The effects of venous occlusion on cerebral blood flow characteristics during ECMO. , 1996, Journal of pediatric surgery.

[14]  L. Tyszczuk,et al.  Role of ECMO in the treatment of respiratory syncytial virus bronchiolitis: a collaborative report. , 1995, Archives of disease in childhood. Fetal and neonatal edition.

[15]  R. Zimmerman,et al.  MRI, MRA, and neurodevelopmental outcome following neonatal ECMO. , 1995, Pediatric neurology.

[16]  E. Wang,et al.  Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. , 1995, The Journal of pediatrics.

[17]  P. Kochanek,et al.  Extracorporeal membrane oxygenation for pediatric respiratory failure: Five‐year experience at the University of Pittsburgh , 1994, Critical care medicine.

[18]  R. Bartlett,et al.  Venovenous compares favorably with venoarterial access for extracorporeal membrane oxygenation in neonatal respiratory failure. , 1993, The Journal of thoracic and cardiovascular surgery.

[19]  A. Costarino,et al.  Adult respiratory distress syndrome in children: associated disease, clinical course, and predictors of death. , 1993, The Journal of pediatrics.

[20]  R. Clark,et al.  Effects of venovenous extracorporeal membrane oxygenation on cardiac performance as determined by echocardiographic measurements. , 1993, The Journal of pediatrics.

[21]  D. Notterman,et al.  Acute hypoxemic respiratory failure in infants and children: Clinical and pathologic characteristics , 1992, Critical care medicine.

[22]  D. Vernon,et al.  Mortality rates and prognostic variables in children with adult respiratory distress syndrome. , 1991, The Journal of pediatrics.

[23]  R. Bartlett,et al.  Hemodynamic instability after the initiation of extracorporeal membrane oxygenation: Role of ionized calcium , 1991, Critical care medicine.

[24]  R. Arensman,et al.  Extracorporeal membrane oxygenation for nonneonatal respiratory failure. , 1991, Journal of pediatric surgery.

[25]  G. Martin,et al.  Cardiac performance in infants referred for extracorporeal membrane oxygenation. , 1991, The Journal of pediatrics.

[26]  F. Walther,et al.  Left and right ventricular output in newborn infants undergoing extracorporeal membrane oxygenation , 1990, Critical care medicine.

[27]  J. Wesley,et al.  Venovenous Perfusion in ECMO for Newborn Respiratory Insufficiency: A Clinical Comparison with Venoarterial Perfusion , 1985, Annals of surgery.

[28]  R. Bartlett,et al.  Venovenous extracorporeal membrane oxygenation in neonates with respiratory failure. , 1983, Journal of pediatric surgery.

[29]  R. Bartlett,et al.  Mortality is directly related to the duration of mechanical ventilation before the initiation of extracorporeal life support for severe respiratory failure. , 1997, Critical care medicine.

[30]  J. Fackler,et al.  The impact of extracorporeal membrane oxygenation on survival in pediatric patients with acute respiratory failure. Pediatric Critical Care Study Group. , 1996, Critical care medicine.

[31]  R. Clark,et al.  Efficacy of venovenous extracorporeal membrane oxygenation for neonates with respiratory and circulatory compromise. , 1993, The Journal of pediatrics.

[32]  M. Mueckler,et al.  The Effect of Extracorporeal Membrane Oxygenation on Coronary Perfusion and Regional Blood Flow Distribution , 1992, Pediatric Research.

[33]  R. Bartlett,et al.  Total respiratory support with venovenous (VV) ECMO. , 1982, Transactions - American Society for Artificial Internal Organs.